CHRISTOPHER SORENSEN: Open Payments
NPI 1912228230 · DRAPER, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$541 in 24 payments from 11 companies in 2025. Trend: 2023 $283 · 2024 $450 · 2025 $541
Food & beverage: $541
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 4 | $120 |
| Neurocrine BioSciences, Inc. | 5 | $111 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $61 |
| Teva Pharmaceuticals USA, Inc. | 3 | $61 |
| ABBVIE INC. | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Alkermes, Inc. | 1 | $16 |
| Corium, LLC | 1 | $15 |
Products named: FANAPT, INGREZZA, CAPLYTA, AUSTEDO XR, VRAYLAR, REXULTI, SPRAVATO, TRINTELLIX.
Industry payments across UT — which companies pay providers there.
